A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma.
about
A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@en
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@nl
type
label
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@en
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@nl
prefLabel
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@en
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@nl
P2093
P2860
P1433
P1476
A Phase I/II Study for Dose-fi ...... atients with Multiple Myeloma.
@en
P2093
Kenshi Suzuki
Kiyohiko Hatake
Masafumi Taniwaki
Noriko Watanabe
Shinsuke Iida
Takaaki Chou
Tetsuji Tsukamoto
P2860
P304
P356
10.2169/INTERNALMEDICINE.9567-17
P577
2017-12-08T00:00:00Z